hydralazine has been researched along with Cardiomyopathy, Hypertrophic in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 14-year-old patient with pheochromocytoma is described in whom myocardial ischaemia occurred following hydralazine administration." | 7.67 | Pheochromocytoma and hydralazine-induced myocardial ischaemia in a 14-year-old boy. ( Friedman, E; Katznelson, D; Mandel, M; Sack, J, 1986) |
| "Each infant had congestive heart failure and angiographic evidence of markedly depressed left ventricular ejection fraction (0." | 5.27 | Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure. ( Appleton, S; Artman, M; Boucek, RJ; Graham, TP; Parrish, MD, 1987) |
| "A 14-year-old patient with pheochromocytoma is described in whom myocardial ischaemia occurred following hydralazine administration." | 3.67 | Pheochromocytoma and hydralazine-induced myocardial ischaemia in a 14-year-old boy. ( Friedman, E; Katznelson, D; Mandel, M; Sack, J, 1986) |
| "Each infant had congestive heart failure and angiographic evidence of markedly depressed left ventricular ejection fraction (0." | 1.27 | Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure. ( Appleton, S; Artman, M; Boucek, RJ; Graham, TP; Parrish, MD, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siedlecki, AM | 1 |
| Jin, X | 1 |
| Muslin, AJ | 1 |
| Unverferth, DV | 1 |
| Mehegan, JP | 1 |
| Magorien, RD | 1 |
| Unverferth, BJ | 1 |
| Leier, CV | 1 |
| Friedman, E | 1 |
| Mandel, M | 1 |
| Katznelson, D | 1 |
| Sack, J | 1 |
| Artman, M | 1 |
| Parrish, MD | 1 |
| Appleton, S | 1 |
| Boucek, RJ | 1 |
| Graham, TP | 1 |
1 trial available for hydralazine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Hypertrophic; Drug Combinations; Female; Heart; Heart Failure; Hemodynamics; H | 1983 |
3 other studies available for hydralazine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.
Topics: Animals; Blood Pressure; Cardiomegaly; Cardiomyopathy, Hypertrophic; Carrier Proteins; Extracellular | 2009 |
Pheochromocytoma and hydralazine-induced myocardial ischaemia in a 14-year-old boy.
Topics: Adolescent; Adrenal Gland Neoplasms; Cardiomyopathy, Hypertrophic; Coronary Disease; Humans; Hydrala | 1986 |
Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure.
Topics: Angiography; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart | 1987 |